Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 6:13:754191.
doi: 10.3389/fphar.2022.754191. eCollection 2022.

Pharmacological Properties of Ginsenoside Re

Affiliations
Review

Pharmacological Properties of Ginsenoside Re

Xiao-Yan Gao et al. Front Pharmacol. .

Abstract

Ginsenoside Re is a protopanaxatriol-type saponin extracted from the berry, leaf, stem, flower bud, and root of Panax ginseng. In recent years, ginsenoside Re (Re) has been attracting attention as a dietary phytochemical. In this review, studies on Re were compiled by searching a combination of keywords, namely "pharmacology," "pharmacokinetics," and "toxicology," in the Google Scholar, NCBI, PubMed, and Web of Science databases. The aim of this review was to provide an exhaustive overview of the pharmacological activities, pharmacokinetics, and toxicity of Re, focusing on clinical evidence that has shown effectiveness in specific diseases, such as diabetes mellitus, nervous system diseases, inflammation, cardiovascular disease, and cancer. Re is also known to eliminate virus, enhance the immune response, improve osteoporosis, improve skin barrier function, enhance intracellular anti-oxidant actions, regulate cholesterol metabolism, alleviate allergic responses, increase sperm motility, reduce erectile dysfunction, promote cyclic growth of hair follicles, and reduce gastrointestinal motility dysfunction. Furthermore, this review provides data on pharmacokinetic parameters and toxicological factors to examine the safety profile of Re. Such data will provide a theoretical basis and reference for Re-related studies and future applications.

Keywords: bioactive component; ginsenoside Re; pharmacokinetics; pharmacological activities; toxicology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic diagram depicting the beneficial effects of Re.

References

    1. Attele A. S., Zhou Y. P., Xie J. T., Wu J. A., Zhang L., Dey L., et al. (2002). Antidiabetic Effects of Panax Ginseng berry Extract and the Identification of an Effective Component. Diabetes 51 (6), 1851–1858. 10.2337/diabetes.51.6.1851 - DOI - PubMed
    1. Bae E. A., Shin J. E., Kim D. H. (2005). Metabolism of Ginsenoside Re by Human Intestinal Microflora and its Estrogenic Effect. Biol. Pharm. Bull. 28 (10), 1903–1908. 10.1248/bpb.28.1903 - DOI - PubMed
    1. Bae H. M., Cho O. S., Kim S. J., Im B. O., Cho S. H., Lee S., et al. (2012). Inhibitory Effects of Ginsenoside Re Isolated from Ginseng berry on Histamine and Cytokine Release in Human Mast Cells and Human Alveolar Epithelial Cells. J. Ginseng Res. 36 (4), 369–374. 10.5142/jgr.2012.36.4.369 - DOI - PMC - PubMed
    1. Bai C. X., Sunami A., Namiki T., Sawanobori T., Furukawa T. (2003). Electrophysiological Effects of Ginseng and Ginsenoside Re in guinea Pig Ventricular Myocytes. Eur. J. Pharmacol. 476 (1-2), 35–44. 10.1016/s0014-2999(03)02174-5 - DOI - PubMed
    1. Bai C. X., Takahashi K., Masumiya H., Sawanobori T., Furukawa T. (2004). Nitric Oxide-dependent Modulation of the Delayed Rectifier K+ Current and the L-type Ca2+ Current by Ginsenoside Re, an Ingredient of Panax Ginseng, in guinea-pig Cardiomyocytes. Br. J. Pharmacol. 142 (3), 567–575. 10.1038/sj.bjp.0705814 - DOI - PMC - PubMed

LinkOut - more resources